Sentences with phrase «develop synthetic vaccine»

Not exact matches

The American company United Biomedical is developing a vaccine made from synthetic protein segments that mimic part of HIV.

Using a novel synthetic platform for creating vaccines originally developed in the laboratory of David Weiner, PhD, a professor of Pathology and Laboratory Medicine from the Perelman School of Medicine at the University of Pennsylvania, a team led by his colleagues at the Johns Hopkins University School of Medicine, has successfully eradicated precancerous cervical lesions in nearly half of the women who received the investigational vaccine in a clinical trial.

Researchers have developed a vaccine for one of the most dangerous types of synthetic cathinones, or bath salts.

After constructing the first synthetic bacterial cell and the first minimal bacterial cell, JCVI scientists are using the groundbreaking techniques used in these milestones to construct synthetic flu vaccines, develop unique new sources of insulin, and more efficient means to produce algae - based biofuels.

Synthetic Genomics (SGI) and the J. Craig Venter Institute (JCVI) have formed a new company, Synthetic Genomics Vaccines (SGVI), to develop next - generation vaccines based on synthetic genome teSynthetic Genomics (SGI) and the J. Craig Venter Institute (JCVI) have formed a new company, Synthetic Genomics Vaccines (SGVI), to develop next - generation vaccines based on synthetic genome teSynthetic Genomics Vaccines (SGVI), to develop next - generation vaccines based on synthetic genome tecVaccines (SGVI), to develop next - generation vaccines based on synthetic genome tecvaccines based on synthetic genome tesynthetic genome technology.

Sept. 12, 2017 - A multidisciplinary scientific team at Lawrence Livermore National Laboratory (LLNL) has made significant advances in developing a vaccine for chlamydia using synthetic biology, sponsored by a two - year National Institutes of Health (NIH) grant.

PHILADELPHIA - Using a novel synthetic platform for creating vaccines originally developed in the laboratory of David Weiner, PhD, a professor of Pathology and Laboratory Medicine from the Perelman School of Medicine at the University of Pennsylvania, a team led by his colleagues at the Johns Hopkins University School of Medicine, has successfully eradicated precancerous cervical lesions in nearly half of the women who received the investigational vaccine in a clinical trial.